Navigation Links
The year 2040: Double the pollen, double the allergy suffering?
Date:11/8/2012

ANAHEIM, CA. (November 9, 2012) With this year's unseasonably warm temperatures and extended seasons, many have coined 2012 as being the worst for allergies. But if you thought your symptoms were worse than ever, just wait until the year 2040.

According to a study being presented by allergist Leonard Bielory, M.D., at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), pollen counts are expected to more than double by 2040.

"Climate changes will increase pollen production considerably in the near future in different parts of the country," said Dr. Bielory, ACAAI board member and fellow. "Economic growth, global environment sustainability, temperature and human-induced changes, such as increased levels of carbon dioxide, are all responsible for the influx that will continue to be seen."

In the year 2000, pollen counts averaged 8,455. Fast forward to 2040, and these counts are anticipated to reach 21,735. Researchers predict counts in 20-year increments up to the year 2100, and are incorporating various climatic factors in their models including weather patterns, changes in precipitation and temperature. The study, taking place at Rutgers University in New Brunswick, N.J., is ongoing to analyze various allergenic plants being grown in climate chambers mimicking future conditions.

While pollen counts will progressively increase over the years, the study also found the sneezing season will begin earlier every year.

"In 2000, annual pollen production began on April 14, and peaked on May 1," said Dr. Bielory. "Pollen levels are predicted to peak earlier on April 8, 2040. If allergy sufferers begin long-term treatment such as immunotherapy (allergy shots) now, they will have relief long before 2040 becomes a reality."

An earlier report by the same researchers demonstrated an increase in ragweed pollen in a section of the country, from Texas to the Canadian border, over the past 25 years. This was associated with an increase of ragweed pollen by two to three weeks as one moves north.

ACAAI allergists recommend allergy sufferers begin treating their symptoms with over-the-counter or prescribed medications two weeks before symptoms usually start. While there isn't a cure for allergies, immunotherapy is the only treatment that can prevent disease progression. It can also result in health care savings of 41 percent.

For allergy sufferers looking to combat seasonal symptoms, ACAAI suggests:

  • Know your triggers. You may think you know that pollen is causing your suffering, but other substances may be involved as well. More than two-thirds of seasonal allergy sufferers actually have year-round symptoms. An allergist can help you find the source of your suffering and treat more than just symptoms.
  • Work with your allergist to devise strategies to avoid your triggers, such as:
    • Monitor pollen and mold counts most media report this information during allergy seasons.
    • Keep windows and doors shut at home, and in your car during allergy season.
    • Stay inside during mid-day and afternoon hours when pollen counts are highest.
    • Take a shower, wash hair and change clothing after being outdoors working or playing.
    • Wear a mask when doing outdoor chores like mowing the lawn. An allergist can help you find the type of mask that works best.


'/>"/>

Contact: Christine Westendorf
christinewestendorf@acaai.org
847-427-1200
American College of Allergy, Asthma, and Immunology
Source:Eurekalert

Related medicine news :

1. Double assault on tough types of leukemias
2. Early Menopause May Double Heart Disease Risk, Study Says
3. Double drug combo could shut down abnormal blood vessel growth that feeds disease
4. Adding bavituximab to second-line chemotherapy doubles response rate
5. MRSA cases in academic hospitals double in 5 years: study
6. Snacking and BMI linked to double effect of brain activity and self-control
7. Moms Pot Use Doubles Risk of Preemie Birth: Study
8. Osteoarthritis risk not diminished in double bundle ACL surgeries
9. As Obesity Rates Rise, Cases of Kidney Stones Double: Study
10. Common acne medication doubles risk of eye infection
11. Study finds number of battery-related emergency department visits by children more than doubles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a very high-dynamic ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R Burton Healthcare ... device, was featured in a study indicating superior performance against competitive products in ... of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published in ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, ... and poetry collections. , “I have been writing since high school and have ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details What can be ... going to grow at the fastest rates? This visiongain ... trends, opportunities and prospects. Our 190-page report provides ... areas in the industry and the future market prospects. ... the all the major categories of the ophthalmic devices ...
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor ... market is expected to grow at a CAGR of 27.1% ... 38.7% in the second half of the forecast period. The market ... to 2027. The market is estimated at $1,058 million in 2016, ... ...
Breaking Medicine Technology: